NOXA1 and colorectal cancer: Notably, Epithelial-Mesenchymal Transition, hypoxia, angiogenesis, and activated inflammatory responses contribute to the poor prognosis of colorectal cancer, and NOXA1 has been found to be involved in vascular inflammation; thus, the expression of Noxa1 may predict poor prognosis in CRC patients12.